Hirte H - Search Results

1

Systemic therapy for recurrent, persistent, or metastatic cervical cancer: a clinical practice guideline.

Hirte H, Kennedy EB, Elit L, Fung Kee Fung M. Hirte H, et al. Curr Oncol. 2015 Jun;22(3):211-9. doi: 10.3747/co.22.2447. Curr Oncol. 2015. PMID: 26089720 Free PMC article.

2

Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review.

Hirte HW, Strychowsky JE, Oliver T, Fung-Kee-Fung M, Elit L, Oza AM. Hirte HW, et al. Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1194-204. doi: 10.1111/j.1525-1438.2007.00900.x. Epub 2007 Jun 1. Int J Gynecol Cancer. 2007. PMID: 17540006 Review.

3

Optimal chemotherapy treatment for women with recurrent ovarian cancer.

Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P. Fung-Kee-Fung M, et al. Among authors: hirte hw. Curr Oncol. 2007 Oct;14(5):195-208. doi: 10.3747/co.2007.148. Curr Oncol. 2007. PMID: 17938703 Free PMC article.

4

Outcomes for systemic therapy in women with ovarian cancer.

Elit L, Chartier C, Oza A, Hirte H, Levine M, Paszat L. Elit L, et al. Among authors: hirte h. Gynecol Oncol. 2006 Nov;103(2):554-8. doi: 10.1016/j.ygyno.2006.03.052. Epub 2006 May 24. Gynecol Oncol. 2006. PMID: 16725183

5

Novel strategies for systemic treatment of endometrial cancer.

Elit L, Hirte H. Elit L, et al. Among authors: hirte h. Expert Opin Investig Drugs. 2000 Dec;9(12):2831-53. doi: 10.1517/13543784.9.12.2831. Expert Opin Investig Drugs. 2000. PMID: 11093356 Review.

6

Chemotherapy for recurrent epithelial ovarian cancer previously treated with platinum--a systematic review of the evidence from randomized trials.

Fung MF, Johnston ME, Eisenhauer EA, Elit L, Hirte HW, Rosen B; Cancer Care Ontario Practice Guidelines Initiative Gynecology Disease Site Group. Fung MF, et al. Among authors: hirte hw. Eur J Gynaecol Oncol. 2002;23(2):104-10. Eur J Gynaecol Oncol. 2002. PMID: 12013102 Review.

7

Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis.

Lukka H, Hirte H, Fyles A, Thomas G, Elit L, Johnston M, Fung MF, Browman G; Cancer Care Ontario Practice Guidelines Initiative Gynecology Disease Site Group. Lukka H, et al. Among authors: hirte h. Clin Oncol (R Coll Radiol). 2002 Jun;14(3):203-12. doi: 10.1053/clon.2002.0076. Clin Oncol (R Coll Radiol). 2002. PMID: 12109823

8

Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.

Elit L, Oliver TK, Covens A, Kwon J, Fung MF, Hirte HW, Oza AM. Elit L, et al. Cancer. 2007 Feb 15;109(4):692-702. doi: 10.1002/cncr.22466. Cancer. 2007. PMID: 17238181 Free article. Review.

9

Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179).

Kollmannsberger C, Hirte H, Siu LL, Mazurka J, Chi K, Elit L, Walsh W, Sederias J, Doyle A, Eisenhauer EA, Oza AM. Kollmannsberger C, et al. Among authors: hirte h. Ann Oncol. 2012 Jan;23(1):238-244. doi: 10.1093/annonc/mdr063. Epub 2011 Mar 29. Ann Oncol. 2012. PMID: 21447615 Free PMC article. Clinical Trial.

10

A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel.

Kwon JS, Elit L, Finn M, Hirte H, Mazurka J, Moens F, Trim K. Kwon JS, et al. Among authors: hirte h. Gynecol Oncol. 2002 Mar;84(3):420-5. doi: 10.1006/gyno.2001.6546. Gynecol Oncol. 2002. PMID: 11855881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page